Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-29 @ 11:43 PM
Study NCT ID:
NCT05584332
Status:
TERMINATED
Last Update Posted:
2023-07-21
First Post:
2022-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
Sponsor:
Shanghai Bovax Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-23
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-12
First Submit QC Date:
None
Study First Post Date:
2022-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-20
Last Update Post Date:
2023-07-21
Last Update Post Date Type:
ACTUAL